CAMBRIDGE, Mass.–(BUSINESS WIRE)–ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced that Amit D. Munshi, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 8:30 a.m. PT in San Francisco, CA.
About ReNAgade Therapeutics
ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing, and gene insertion to develop new medicines.
To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines.
ReNAgade Therapeutics—RNA Without Limits
For more information about the company, its technologies, and its leadership, visit www.renagadetx.com
Contacts
Investor Relations:
Emily Brabbit, Argot Partners
(212) 600-1902
renagade@argotpartners.com
Media Relations:
Sarah Sutton, Argot Partners
(212) 600-1902
renagade@argotpartners.com
Key takeaways:The CBSE 2027 exam timetable PDF for Class 10 and Class 12 is expected…
Key takeaways:Chand nikalne ka time varies across cities like Delhi, Mumbai, Kolkata, Bengaluru, Agra, and…
Key takeaways:Justice Sanjay Kumar barred advocates from approaching court officers after a lawyer's son abused…
Key takeaways:Sri Lanka captain Chamari Athapaththu went unsold with no bids received at the WPL…
Key takeaways:There is no single universal moon timing today; moonrise depends on city, date, and…
Key takeaways:City Union Bank reported Q2 FY27 net profit of ₹416 crore, up 27% year-on-year…